Member Exclusive News

The week in industry: Successful end to respiratory disease research collaboration

This week: Approval of combination treatment for NSCLC, €3.5 million milestone payment received in auto-immune disease collaboration and additional funding for the continued development of antifungal therapies.

Go to the profile of RxNet
Dec 05, 2019
0
0

Please sign in or register for FREE

No comments yet.